Poly Medicure schedules investor meets from May 26

Poly Medicure Limited has scheduled a series of one-on-one meetings with analysts and investors commencing May 26, 2026. The company officials will engage with four major entities over four days, adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meetings will be conducted in physical format across two locations. The Registered Office in New Delhi will host two sessions, while the company's Plant in Faridabad will accommodate the remaining interactions. The company has explicitly stated that no unpublished price sensitive information will be shared during these discussions.

Schedule of Meetings

The following table outlines the detailed schedule for the investor meets:

S. No.	Name of Analyst/ Investor Meet	Meeting Date	Venue	Format
1.	Aberdeen	Tuesday, 26th May 2026 at 02:00 PM	Physical Meeting at Company's Registered Office	One-on-one
2.	Trust AMC	Wednesday, 27th MAY 2026 at 10:30 AM	Physical Meeting at Company's Plant, Faridabad	One-on-one
3.	Wellington Management	Thursday, 28th May 2026 at 11:15 AM	Physical Meeting at Company's Registered Office	One-on-one
4.	Wasatch	Friday, 29th May 2026 at 10:30 AM	Physical Meeting at Company's Plant, Faridabad	One-on-one

The company noted that the above schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company itself. Further details regarding the meetings are available on the official website of poly medicure .

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.19%	+3.22%	+5.02%	-17.57%	-36.79%	+47.21%

Poly Medicure has announced that an earnings conference call will be held on Monday, May 25, 2026, to discuss the audited financial results for the quarter and year ended March 31, 2026. The call is scheduled to commence at 5:00 PM India time pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Details

The management team will present the financial performance for Q4 and FY26. Key executives representing the company during the call include:

Name	Designation
Himanshu Baid	Managing Director
Naresh Vijayvergiya	Chief Financial Officer
Rahul Gautam	President- Strategy & Corporate Development

Access Information

Shareholders and analysts can join the conference call using the universal dial-in numbers provided. Registration for the Diamond Pass is available via a dedicated link. The coordinator for the event is Apoorv Rastogi.

Parameter	Details
Date	Monday, May 25, 2026
Time	5:00 - 6:00 PM
Universal Dial-In	+91 22 62801368, +91 22 71158269
Coordinator Email	apoorv.rastogi@polymedicure.com

Board Meeting Context

This earnings call follows the board meeting scheduled on the same day to consider and approve the audited financial results for the financial year ended March 31, 2026. The board is also scheduled to consider the recommendation of a final dividend, if any. The trading window for dealing in the company's securities remains closed until May 27, 2026.